Given the wide variability in clinical presentation of IBD, we cannot exclude the possibility that recessive NOD2 carriers exhibit subclinical phenotypes not formally diagnosed as IBD or that they may eventually develop IBD. Here, NOD2 is linked to inflammatory bowel disease.